What is the ticker symbol for Pyxis Oncology?

Pyxis Oncology trades under the ticker PYXS on NASDAQ.

What sector does Pyxis Oncology operate in?

Pyxis Oncology is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze PYXS in a portfolio?

PortView shows PYXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Pyxis Oncology (PYXS) Stock Analysis

NASDAQHealthcareBiotechnology

$3.55+3.27%

1-year price historyRange $1.06 – $5.34

52-week range$3.55

$1.03$5.55

What Pyxis Oncology does

Pyxis Oncology, Inc. operates as a preclinical biopharmaceutical company focused on developing novel therapeutic approaches to combat various forms of cancer. Its investigational immune-oncology pipeline includes PYX-106, a fully human immunoglobulin G1 (IgG1) antibody designed to target siglec-15, which is being explored for its potential efficacy against thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors. Additionally, PYX-102 is an immune-therapeutic currently under investigation for the treatment of solid tumors. The company's portfolio also features a range of investigational antibody-drug conjugate (ADC) candidates: PYX-201, a novel ADC being developed for NSCLC, breast cancer, and other solid tumors; PYX-202, another novel ADC aimed at small cell lung cancer (SCLC), soft tissue sarcoma, and other solid tumors; and PYX-203, an ADC undergoing evaluation for acute myeloid leukemia and myeloid dysplastic syndrome. Pyxis Oncology was founded in 2018 and is based in Cambridge, Massachusetts.

Key metrics

Market cap

$225.06M

P/E (TTM)

-2.52

EPS (TTM)

$-1.41

Beta

1.32

Dividend yield

0.00%

Revenue / share

$0.17

50-day avg

$2.87

200-day avg

$2.29

52-week high

$5.55

52-week low

$1.03

CEO

Thomas Civik

ETFs linked to PYXS

Broad-market and Healthcare sector ETFs an investor holding Pyxis Oncology is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how PYXS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PYXS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Pyxis Oncology?: Pyxis Oncology trades under the ticker PYXS on NASDAQ.
Which exchange is PYXS listed on?: PYXS is listed on NASDAQ.
What sector does Pyxis Oncology operate in?: Pyxis Oncology is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PYXS in a portfolio?: PortView shows PYXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.